» Articles » PMID: 9826580

OX-40: Life Beyond the Effector T Cell Stage

Overview
Journal Semin Immunol
Date 1998 Nov 25
PMID 9826580
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

The OX-40 receptor (OX-40R) is a transmembrane protein found on the surface of activated CD4(+) T cells. When engaged by an agonist such as anti-OX-40 antibody or the OX-40 ligand (OX-40L) during antigen presentation to T cell lines, the OX-40R generates a costimulatory signal that is as potent as CD28 costimulation. Engagement of OX-40R enhances effector and memory-effector T cell function by up-regulating IL-2 production and increasing the life-span of effector T cells. We hypothesize that the signal generated by the OX-40R inhibits activation-induced T cell death (AICD) and thereby increases the number of cells differentiating from the effector to memory T cell stage. In experimental autoimmune encephalomyelitis (EAE) OX-40R+ T cells are found only within the inflammatory site [central nervous system (CNS)]. Sorting OX-40R+ T cells from the CNS of animals with EAE revealed that they are autoantigen-specific T cells. Therefore, OX-40R-specific therapies were devised to eliminate or inhibit autoreactive T cells, while sparing the remainder of the T cell repertoire. In contrast, in vivo costimulation through the OX-40R in animals with cancer generated enhanced tumor-specific immunity leading to improved tumor-free survival. Thus, manipulation of the OX-40R during inflammatory responses can alter effector CD4(+) T cell function by enhancing or limiting T cell activation and survival.

Citing Articles

Prognostic significance of TNFRSF4 expression and development of a pathomics model to predict expression in hepatocellular carcinoma.

Yan Z, Li X, Li Z, Liu S, Chang H Heliyon. 2024; 10(11):e31882.

PMID: 38841483 PMC: 11152671. DOI: 10.1016/j.heliyon.2024.e31882.


Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes.

Nagai H, Azuma M, Sato A, Shibui N, Ogawara S, Tsutsui Y Cells. 2023; 12(12).

PMID: 37371066 PMC: 10297085. DOI: 10.3390/cells12121596.


The Unfolded Protein Response at the Tumor-Immune Interface.

Zanetti M, Xian S, Dosset M, Carter H Front Immunol. 2022; 13:823157.

PMID: 35237269 PMC: 8882736. DOI: 10.3389/fimmu.2022.823157.


In vivo NIR-II structured-illumination light-sheet microscopy.

Wang F, Ma Z, Zhong Y, Salazar F, Xu C, Ren F Proc Natl Acad Sci U S A. 2021; 118(6).

PMID: 33526701 PMC: 8017937. DOI: 10.1073/pnas.2023888118.


Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface.

Lee W, Seo D, Lim S, Suk K Front Immunol. 2019; 10:262.

PMID: 30838001 PMC: 6389649. DOI: 10.3389/fimmu.2019.00262.